PRISM Stock IndexesCurrent Value% Change (Daily)% Change (Inception)Most ActiveTop % GainersTop % Losers
AdTech and Media$88.601.5%-11.4%SIRI 39,995 BBLR  45.455%PODC -5.517%
Biotech$189.90-1.8%89.9%VXRT 4,195 BLRX  5.397%ADVM -13.819%
Cannabis$110.90-1.2%10.9%TLRY 21,774 HITI  2.186%JUSHF -9.45%
Consumer Products$80.800.3%-19.2%PTON 16,871 OTLY  12.5%NUS -5.41%
EV$136.40-2.8%36.4%RIVN 46,364 NKLA  8.362%LTHM -8.532%
Global Health$87.10-2.1%-12.9%LGVN 10,210 NKGN  7.207%GUTS -8.372%
Healthcare$79.000.3%-21.0%HIMS 10,770 HCTI  15.976%HIMS -4.664%
NextGen Tech & AI$90.00-0.9%-10.0%SOUN 27,674 SLNH  10.19%IONQ -9.501%
New Energy$75.80-4.3%-24.2%MAXN 56,409 NOVA  2.929%SPWR -55.013%
MedDevices$96.90-0.5%-3.1%AEMD 4,781 MDGS  10.28%BSEM -7.233%
Mental Health$84.10-0.5%-15.9%TALK 1,516 NUMIF  10.554%ABVC -6.19%
Oil & Gas$96.80-1.1%-3.2%SWN 14,509 MXC  2.095%RES -6.181%
Pharmaceuticals$104.70-0.6%4.7%BDRX 5,057 IOBT  15.329%BDRX -14.939%
Psychedelics$86.80-3.3%-13.2%CYBN 4,254 RLMD  2.589%MIRA -12.366%
Women’s Health$149.900.2%49.9%VSTM 900 DARE  10.972%STTK -5.172%
Zombie$103.30-0.1%3.3%AMC 60,679 DASH  5.804%BYND -4.666%

Prism View

ChargePoint (CHPT) Powers Forward: Leading the NEVI Program with First Phase Completion in Rhode Island

PRISM Emerging EV Index company, Chargepoint (CHPT) is a leading provider of networked charging solutions for electric vehicles (EVs). Today the company announced its ongoing leadership in enabling DC fast charging at locations funded by the National Electric Vehicle Infrastructure…

Making Money and Music: LiveOne (LVO) Reports Preliminary Record-Breaking Q1 Revenue and EBITDA

AdTech and Media Index company and creator-first music tech platform LiveOne (LVO) announced preliminary and unaudited results for its first quarter. The company anticipates record revenue of $33.1M, an increase of 20% from the previous year’s first quarter. Its expected…

Stocks making the biggest moves midday: CrowdStrike, Plug Power, Comerica and more

Here's a rundown of the companies creating a stir in midday trades. CrowdStrike has caught the market's attention with its shares falling over 10% after a cybersecurity glitch caused major IT disruptions across industries such as airlines, hospitals, and financial…

Stocks Drop Ahead of Crucial Tech Earnings: Markets Wrap

Tech results are coming at a critical moment for Wall Street as the S&P 500 heads…

Are You Still Watching? Netflix Posts Q2 Earnings Beat, Lowers Q3 Revenue Guidance

The streaming giant Netflix (NFLX) reported earnings after the close on Thursday that beat Q2 EPS…

Stocks making the biggest premarket moves: CrowdStrike, American Express, SLB, Travelers and more

Get the scoop on the businesses making major waves in premarket trading: CrowdStrike's shares took a…

Lights Out! SunPower (SPWR) Plummets Almost 30% After Pausing Some Operations

The PRISM New Energy laggard SunPower Corporation (SPWR) saw its shares plunge after announcing it is…

Stocks making the biggest moves premarket: Domino’s, Warner Bros. Discovery, United Airlines and more

Here's a quick update on companies to watch out for this morning. Domino's Pizza saw their…

Fields of Promise? KLX Energy (KLXE) Leads PRISM Oil and Gas Index Today, Here’s Why

Today the PRISM Oil and Gas Index company KLX Energy (KLXE) provided preliminary Q2 financial results…

Feature Story

PRISM Consumer Airline and Travel Insights: The Seatbelt Sign Is On.

Airline commentary has been making headlines as quarterly earnings are being released and economic reports are providing additional travel insights to the investment community. June’s CPI report that surprised estimates and reported a drop in prices for the first time since the pandemic, specifically mentioned airfares to be a segment that contributed to the m/m decline in prices. Additionally, the term “consumer resilience” is being scrutinized and debated between bulls and bears. Regardless how much or little one believes in the strength of consumers financial health, various reports across the industry continue to echo that people are still traveling but how they are traveling may be a better indicator of the true financial health of the US consumer.

So far here is what the airlines who have reported earnings have had to say:

(more…)

Q&A Corner

Ellen Kim

Soligenix’s HyBryte™: Lighting the Way Towards Commercial Success with Promising FLASH Study Results

Cutaneous T-cell lymphoma (CTCL) is a rare form of non-Hodgkin’s lymphoma with no FDA-approved first-line treatments on the market. Approximately 3,000 new CTCL cases are diagnosed in the United States each year and more than 20,000 patients are living with CTCL. Late-Stage biotech company Soligenix (Nasdaq: SNGX) is developing and moving toward potential commercialization of HyBryte™ (synthetic hypericin) as a novel first-in-class photodynamic therapy that uses safe visible light for the treatment of early-stage CTCL.

Ellen Kim, MD, Director, Penn Cutaneous Lymphoma Program, Vice Chair of Clinical Operations, Dermatology Department, and Professor of Dermatology at the Hospital of the University of Pennsylvania was the Lead Principal Investigator for Soligenix’s Phase 3 FLASH (Fluorescent Light Activated Synthetic Hypericin) study in CTCL.

On July 9th, Dr. Kim publicly disclosed interim results from an ongoing open-label, investigator-initiated study (IIS) she sponsored evaluating extended HyBryte™ treatment for up to 12 months in patients with early-stage CTCL. This study is currently being supported by a $2.6 million Orphan Products Development Grant awarded by the U.S. Food and Drug Administration (FDA).

We had the chance to sit down with her to discuss the positive preliminary findings as well as what’s next for this potentially breakthrough treatment.

Traders Lens

Domino’s Pizza Group

$DPZ is sliding today after its Q2 earnings fell short of estimates this morning.

4D Molecular Therapeutics Inc.

Biotech company $FDMT has faded pretty hard after starting the day up. The stock is currently down upwards of 30%. Earlier today the company released results from their PRISM Phase 2 Clinical Trial, which they described as positive, but clearly it wasn’t quite what the market was looking for.

AngioDynamics Inc.

$ANGO is leading the Prism MarketView MedDevices index after posting Q4 earnings this morning.

Bio View

Anixa Biosciences Secures Japanese Patent for Breast Cancer Vaccine Technology

Biotechnology company, Anixa Biosciences (Nasdaq: ANIX), has received a “Decision to Grant” notice from the Japan Patent Office (JPO) for a patent application for its breast cancer vaccine technology. Anixa is developing a vaccine that activates the immune system against…

Bionomics Kicks Off Phase 3 Trial for Promising Social Anxiety Disorder Treatment

Bionomics Limited (Nasdaq: BNOX) has begun patient screening for its Phase 3 AFFIRM-1 clinical trial, evaluating the safety and efficacy of BNC210 for the acute, as-needed treatment of social anxiety disorder (SAD). BNC210 is an α7 nicotinic receptor small molecule…

Immuron Reports Record US and Australian Sales of Travelan

Australian biotechnology company, Immuron Limited (Nasdaq: IMRN), has achieved record sales of its over-the-counter immune supplement, Travelan®, an orally administered immunotherapy that reduces the likelihood of contracting Travelers’ Diarrhea, a digestive tract disorder that is commonly caused by pathogenic bacteria…

Clearmind Medicine Surges on Psychoactive Agent’s Impact on Obesity and Binge Behavior

Shares in psychedelic-derived therapeutics company, Clearmind Medicine (Nasdaq: CMND), surged on Monday after the company announced…

Sera Prognostics Rises on Positive Topline Results from Preterm Birth Treatment Study

The Pregnancy Company®, Sera Prognostics (Nasdaq: SERA), has  announced that positive data from its  AVERT PRETERM…

Vistagen Tops PRISM Mental Health Index with Migraine Patent News

Neuroscience-focused biopharmaceutical company, Vistagen Therapeutics (Nasdaq: VTGN), topped the PRISM Mental Health Index on Thursday, rising…

A New Vision for Treating Eye Pain: OKYO Pharma Initiates Phase 2 Trial of OK-101 for Neuropathic Corneal Pain

OKYO Pharma Limited (NASDAQ: OKYO), a leader in the development of novel ophthalmic therapies, saw its…
PRISM Indexes